Alternating or sequential chemotherapy in small cell lung cancer
作者： Kell Østerlind
DOI: 10.1016/0169-5002(89)90165-7
关键词:
摘要:
sci-hub.se 参考文章(10)
R Feld, W K Evans, P Coy, I Hodson, A S MacDonald, D Osoba, D Payne, W Shelley, J L Pater, Canadian multicenter randomized trial comparing sequential and alternating administration of two non-cross-resistant chemotherapy combinations in patients with limited small-cell carcinoma of the lung. Journal of Clinical Oncology. ,vol. 5, pp. 1401- 1409 ,(1987) , 10.1200/JCO.1987.5.9.1401
P J Goodwin, R Feld, W K Evans, J Pater, Cost-effectiveness of cancer chemotherapy: an economic evaluation of a randomized trial in small-cell lung cancer. Journal of Clinical Oncology. ,vol. 6, pp. 1537- 1547 ,(1988) , 10.1200/JCO.1988.6.10.1537
J R Daniels, L Y Chak, B I Sikic, P Lockbaum, M Kohler, S K Carter, R Reynolds, R Bohnen, D Gandara, J Yu, Chemotherapy of small-cell carcinoma of lung: a randomized comparison of alternating and sequential combination chemotherapy programs. Journal of Clinical Oncology. ,vol. 2, pp. 1192- 1199 ,(1984) , 10.1200/JCO.1984.2.11.1192
J.H. Goldie, Mathematical models to predict behaviour of tumours European Journal of Cancer and Clinical Oncology. ,vol. 24, pp. 587- 589 ,(1988) , 10.1016/0277-5379(88)90285-4
John A Elliott, Kell Østerlind, Heine H Hansen, Cyclic alternating 'non-cross resistant' chemotherapy in the management of small cell anaplastic carcinoma of the lung. Cancer Treatment Reviews. ,vol. 11, pp. 103- 113 ,(1984) , 10.1016/0305-7372(84)90002-1
Henrik Roed, Lars L. Vindeløv, IB J. Christensen, Mogens Spang-Thomsen, Heine Høi Hansen, The cytotoxic activity of cisplatin, carboplatin and teniposide alone and combined determined on four human small cell lung cancer cell lines by the clonogenic assay European Journal of Cancer and Clinical Oncology. ,vol. 24, pp. 247- 253 ,(1988) , 10.1016/0277-5379(88)90261-1
Mogens Spang-Thomsen, Heine H. Hansen, Mogens Hansen, Ib J. Christensen, Lars L. Vindeløv, Nis I. Nissen, Fred R. Hirsch, Clonal Heterogeneity of Small-Cell Anaplastic Carcinoma of the Lung Demonstrated by Flow-Cytometric DNA Analysis Cancer Research. ,vol. 40, pp. 4295- 4300 ,(1980)
W. K. EVANS, Superiority of Alternating Non-Cross-Resistant Chemotherapy in Extensive Small Cell Lung Cancer Annals of Internal Medicine. ,vol. 107, pp. 451- 458 ,(1987) , 10.7326/0003-4819-107-4-451
Brian G. Birkhead, Elaine M. Rankin, Stephen Gallivan, Leanne Dones, Robert D. Rubens, A mathematical model of the development of drug resistant to cancer chemotherapy European Journal of Cancer and Clinical Oncology. ,vol. 23, pp. 1421- 1427 ,(1987) , 10.1016/0277-5379(87)90133-7
Gudauskas Ga, Goldie Jh, Coldman Aj, Rationale for the use of alternating non-cross-resistant chemotherapy. Cancer treatment reports. ,vol. 66, pp. 439- 449 ,(1982)